Scilex Holding Company (NASDAQ: SCLX) has experienced a rise in its stock price by 6.21 compared to its previous closing price of 0.31. However, the company has seen a gain of 5.36% in its stock price over the last five trading days. globenewswire.com reported 2025-03-10 that PALO ALTO, Calif., March 10, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that its Board of Directors has approved changing the previously announced record date of January 28, 2025 for its previously announced dividend of Scilex preferred stock (the “Dividend”) to its stockholders and certain other securityholders of Scilex.
Is It Worth Investing in Scilex Holding Company (NASDAQ: SCLX) Right Now?
Company’s 36-month beta value is 0.89.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SCLX is 180.22M, and currently, short sellers hold a 3.49% ratio of that floaft. The average trading volume of SCLX on March 19, 2025 was 1.43M shares.
SCLX’s Market Performance
SCLX’s stock has seen a 5.36% increase for the week, with a -7.07% drop in the past month and a -35.27% fall in the past quarter. The volatility ratio for the week is 10.65%, and the volatility levels for the past 30 days are at 12.45% for Scilex Holding Company The simple moving average for the past 20 days is 8.18% for SCLX’s stock, with a -64.16% simple moving average for the past 200 days.
Analysts’ Opinion of SCLX
Many brokerage firms have already submitted their reports for SCLX stocks, with D. Boral Capital repeating the rating for SCLX by listing it as a “Buy.” The predicted price for SCLX in the upcoming period, according to D. Boral Capital is $22 based on the research report published on January 27, 2025 of the current year 2025.
Alliance Global Partners, on the other hand, stated in their research note that they expect to see SCLX reach a price target of $14. The rating they have provided for SCLX stocks is “Buy” according to the report published on October 16th, 2024.
Rodman & Renshaw gave a rating of “Buy” to SCLX, setting the target price at $13 in the report published on June 13th of the previous year.
SCLX Trading at -11.60% from the 50-Day Moving Average
After a stumble in the market that brought SCLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.72% of loss for the given period.
Volatility was left at 12.45%, however, over the last 30 days, the volatility rate increased by 10.65%, as shares sank -6.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -30.55% lower at present.
During the last 5 trading sessions, SCLX rose by +5.64%, which changed the moving average for the period of 200-days by -70.32% in comparison to the 20-day moving average, which settled at $0.3037. In addition, Scilex Holding Company saw -22.96% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SCLX starting from SHAH JAISIM, who purchase 30,000 shares at the price of $0.46 back on Dec 18 ’24. After this action, SHAH JAISIM now owns 139,333 shares of Scilex Holding Company, valued at $13,800 using the latest closing price.
Ji Henry, the Executive Chairperson of Scilex Holding Company, purchase 8,888 shares at $0.94 during a trade that took place back on Oct 31 ’24, which means that Ji Henry is holding 320,161 shares at $8,351 based on the most recent closing price.
Stock Fundamentals for SCLX
Current profitability levels for the company are sitting at:
- -1.46 for the present operating margin
- 0.66 for the gross margin
The net margin for Scilex Holding Company stands at -1.59. The total capital return value is set at 0.44.
Based on Scilex Holding Company (SCLX), the company’s capital structure generated -0.7 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at -0.41. The interest coverage ratio of the stock is -36.0.
Currently, EBITDA for the company is -109.1 million with net debt to EBITDA at -1.07. When we switch over and look at the enterprise to sales, we see a ratio of 3.03. The receivables turnover for the company is 1.75for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.14.
Conclusion
In a nutshell, Scilex Holding Company (SCLX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
